His main research concerns Lupus erythematosus, Internal medicine, Immunology, Surgery and Gastroenterology. His Lupus erythematosus research includes elements of Epidemiology, Polymorphism, Systemic lupus erythematosus, Connective tissue disease and Lupus anticoagulant. His Lupus nephritis, Cyclophosphamide, Renal function, Prednisolone and Rheumatoid arthritis investigations are all subjects of Internal medicine research.
His research integrates issues of Odds ratio, Genome-wide association study and Disease in his study of Immunology. Chak Sing Lau studied Surgery and Kidney disease that intersect with Renal biopsy and Univariate analysis. His Gastroenterology study integrates concerns from other disciplines, such as Creatinine, Azathioprine and Diet therapy.
The scientist’s investigation covers issues in Internal medicine, Immunology, Lupus erythematosus, Systemic lupus erythematosus and Rheumatology. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Surgery. Gastroenterology is often connected to Lupus nephritis in his work.
His Immunology research incorporates themes from Genome-wide association study and Disease. His work in Lupus erythematosus covers topics such as Connective tissue disease which are related to areas like Systemic disease. His Systemic lupus erythematosus study frequently involves adjacent topics like Disease activity.
Internal medicine, Rheumatology, Systemic lupus erythematosus, Rheumatoid arthritis and Epidemiology are his primary areas of study. The Internal medicine study combines topics in areas such as Tuberculosis and Allergy. His Rheumatology research is multidisciplinary, relying on both Back pain, Axial spondyloarthritis, Infliximab and Proportional hazards model.
His Systemic lupus erythematosus study combines topics in areas such as Dermatology, Prospective cohort study, Cohort study and Immunology. Many of his studies on Immunology involve topics that are commonly interrelated, such as Genome. Chak Sing Lau interconnects Medical prescription and Incidence in the investigation of issues within Epidemiology.
His primary areas of investigation include Internal medicine, Systemic lupus erythematosus, In patient, Prospective cohort study and Drug allergy. His study in Internal medicine is interdisciplinary in nature, drawing from both Serology and Allergy. His studies in Systemic lupus erythematosus integrate themes in fields like Disease activity and Immunology.
In Immunology, he works on issues like Endogeny, which are connected to Rheumatoid arthritis. His research investigates the connection between Drug allergy and topics such as Epidemiology that intersect with issues in Family medicine and Lupus erythematosus. His studies deal with areas such as Lupus nephritis and Anemia as well as Prednisolone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group
T M Chan;F K Li;C S Tang;R W Wong.
The New England Journal of Medicine (2000)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Ivan Fan Ngai Hung;Kwok Cheung Lung;Eugene Yuk Keung Tso;Raymond Liu.
The Lancet (2020)
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
Tak Mao Chan;Fu Keung Li;Colin S.O. Tang;Raymond W.S. Wong.
The New England Journal of Medicine (2000)
Pathogenesis of systemic lupus erythematosus
C C Mok;C S Lau.
Journal of Clinical Pathology (2003)
Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.
Wanling Yang;Nan Shen;Dong-Qing Ye;Qiji Liu;Qiji Liu.
PLOS Genetics (2010)
Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
Yi Ren;Jinling Tang;M. Y. Mok;Albert W. K. Chan.
Arthritis & Rheumatism (2003)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
David M Reid;Jean-Pierre Devogelaer;Kenneth Saag;Christian Roux.
The Lancet (2009)
Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus
Chi Chiu Mok;Jerry S. Lanchbury;David Wai Chan;Chak Sing Lau.
Arthritis & Rheumatism (1998)
Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
Chi Chiu Mok;Chak Sing Lau;Raymond Woon Sing Wong.
Arthritis & Rheumatism (1998)
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Kate Franklyn;Chak Sing Lau;Sandra V Navarra;Worawit Louthrenoo.
Annals of the Rheumatic Diseases (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Hong Kong
University of Hong Kong
University of Dundee
Monash University
University of Hong Kong
Université Catholique de Louvain
University of Alabama at Birmingham
University of Hong Kong
University of Liège
University of Hong Kong
University of Calgary
Hong Kong University of Science and Technology
Institut de Physique du Globe de Paris
Texas A&M University
Texas Tech University
University of California, Riverside
Ehime University
Peking University
University of Seville
Universidade de Ribeirão Preto
University of California, San Diego
Oslo University Hospital
University of British Columbia
University of Denver
Swinburne University of Technology
University of Hawaii at Manoa